Changes in lipoprotein subfraction concentration and composition in healthy individuals treated with the CETP inhibitor anacetrapib-Reference-Cited by-同舟云学术

Changes in lipoprotein subfraction concentration and composition in healthy individuals treated with the CETP inhibitor anacetrapib

Published:2012-03 Issue:3 Volume:53 Page:540-547
ISSN:0022-2275
Container-title:Journal of Lipid Research
language:en
Short-container-title:Journal of Lipid Research

Author:

Krauss Ronald M.,Wojnooski Kathleen,Orr Joseph,Geaney J. Casey,Pinto Cathy Anne,Liu Yang,Wagner John A.,Luk Julie Mabalot,Johnson-Levonas Amy O.,Anderson Matt S.,Dansky Hayes M.

Publisher

Elsevier BV

Subject

Cell Biology,Endocrinology,Biochemistry

Reference30 articles.

1. Residual risk for secondary ischemic events in patients with atherothrombotic disease: opportunity for future improvements in patient care;Pepine;Ann. Med.,2010

2. Beyond statin therapy: a review of the management of residual risk in diabetes mellitus;Judge;J. R. Soc. Med.,2010

3. Plasma cholesteryl ester transfer protein;Tall;J. Lipid Res.,1993

4. Deficiency of serum cholesteryl-ester transfer activity in patients with familial hyperalphalipoproteinaemia;Koizumi;Atherosclerosis.,1985

5. Association of cholesteryl ester transfer protein genotypes with CETP mass and activity, lipid levels, and coronary risk;Thompson;JAMA.,2008

Cited by 86 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High-Density Lipoprotein Subclasses and Their Role in the Prevention and Treatment of Cardiovascular Disease: A Narrative Review;International Journal of Molecular Sciences;2024-07-18

2. Relative increase in production ratio of small dense low-density lipoprotein in acute coronary syndrome with high coronary plaque burden: an ex-vivo analysis;Heart and Vessels;2024-07-17

3. High‐Density Lipoprotein Particle Concentration and Size Predict Incident Coronary Artery Disease Events in a Cohort With Type 1 Diabetes;Journal of the American Heart Association;2024-07-16

4. Ipragliflozin and sitagliptin differentially affect lipid and apolipoprotein profiles in type 2 diabetes: the SUCRE study;Cardiovascular Diabetology;2024-02-08

5. To Determine LDL Phenotypes Using Lipids, Lipoproteins, Apoproteins, and sdLDL Through Association Rule Mining;Journal of Clinical Practice and Research;2024